SEC FORM 4
$9,733,313.24
Caris Life Sciences, Inc. (CAI)
Sale of 393,100 shares at $24.7604 per share.
Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →